Evaluation of an Anti-inflammatory Diet in Autoimmune and Metabolic Diseases

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 23, 2022

Primary Completion Date

November 24, 2023

Study Completion Date

November 24, 2023

Conditions
Type1 DiabetesObesity
Interventions
DIETARY_SUPPLEMENT

Microbiome-targeted diet

The gut microbiota (on stool) and metabolic profile (on stool and urine) will be analyzed at time 0, and the dietary plan will contain specific directions aimed at restoring a proper metagenomic and metabolomic profile of the microbiota.

DIETARY_SUPPLEMENT

Usual care diet

Subjects on the control group will receive general dietetic advice for Obesity or T1D

Trial Locations (2)

20132

Pediatric Unit, Milan

Autoimmune Pathogenesis Unit, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER